Psychosocial stressors and bowel symptoms among Latina women: a population-based study

Nseyo U1, Chen N2, Dani K3, Sevilla C4, Yosufi N2, Dancz C2, Ginsberg D2, Stern M2, Rodriguez L1

Research Type

Clinical

Abstract Category

Anorectal / Bowel Dysfunction

Abstract 640
Open Discussion ePosters
Scientific Open Discussion Session 33
Friday 29th September 2023
12:55 - 13:00 (ePoster Station 4)
Exhibit Hall
Anal Incontinence Constipation Bowel Evacuation Dysfunction Female Urgency, Fecal
1. Department of Urology, Weill Cornell Medicine, 2. Department of Urology, Keck School of Medicine of USC, 3. Keck School of Medicine of USC, 4. Genesis Healthcare Partners
Presenter
Links

Abstract

Hypothesis / aims of study
Psychological stress has a known relationship to symptom prevalence and severity for bowel dysfunction including constipation and the symptom complex of irritable bowel syndrome, as well as, its associated symptoms of fecal urgency and fecal incontinence. The presence of pelvic floor disorders (PFDs) has also been independently associated with presence of bowel symptoms and are relatively understudied in racial/ethnic minority women.  Psychosocial stress as related to discrimination has been implicated as a contributor to poor health outcomes among racial/ethnic minorities and is of particular importance given the higher exposure to environmental and discrimination-based stressors among racial/ethnic minorities. The role of discrimination-related stress in moderating relationship between PFDs and bowel symptoms warrants further study given higher rates of psychosocial stress among marginalized populations. We will evaluate the relationship between bowel symptoms, psychosocial stressors and prevalence of PFDs among Latina women in the community.
Study design, materials and methods
We used data collected through a population-based cross-sectional study of Spanish- and English-speaking Latina women recruited throughout northeast Los Angeles through 2019.  We obtained demographic data and psychosocial measures, specifically the Perceived Stress Scale (PSS), PSS subscores representing protective and negative domains, the Everyday Discrimination Scale (EDS), as well as a chronicity-weighted EDS (CEDS). Symptoms of PFDs were identified by the Pelvic Organ Prolapse Distress Inventory (POPDI-6), Urinary Distress Inventory (UDI-6) and Colorectal-Anal Distress Inventory (CRAD-8) portions of the Pelvic Floor Disorders Inventory (PFDI-20) questionnaire. We considered both presence of PFDs as well as severity. We conducted multivariable logistic regression to test the association between bowel symptoms and the above variables with statistical significance at a p-value <0.05.
Results
We identified a total of 76 women (39.7%) with bowel symptoms. Of those, 25 (13.1%) had FI. Women with bowel symptoms were younger (47.8 vs 5.04, p = 0.27), reported higher levels of perceived stress (16.8 vs 14.3, p = 0.003), specifically in the negative subscore (10.9 vs 8.4, p < 0.001), and had more severe PFDs (p < 0.001). There were non-statistically significant increases in discrimination scores among those with bowel symptoms for both EDS (1.33 vs 1.06, p = 0.12) and CEDS (245.4 vs 196.1, p = 0.39). On multivariable logistic regression analysis (Table 1), PSS negative subscore (OR = 1.1, 1.0 to 1.2, p = 0.02), POPDI-6 severity (OR = 4.2, 1.5 to 11.6, p = 0.005), and UDI-6 severity (OR = 12.6, 4.2 to 33.7, p < 0.001) remained statistically significant.
Interpretation of results
Bowel symptoms among Latina women recruited in the community were associated with both the severity of PFDs as well as perceived stress and chronic discrimination. These results suggest the role of psychosocial stress as a risk factor, or consequence of bowel symptoms.
Concluding message
Further research is needed to understand the complex interaction between psychosocial mediators and PFDs, especially in the setting of severe PFD symptoms.
Disclosures
Funding This work is supported by UL1TR001855 and UL1TR000130 from the National Center for Advancing Translational Science (NCATS) of the U.S. National Institutes of Health. Clinical Trial No Subjects Human Ethics Committee USC IRB Helsinki Yes Informed Consent Yes
25/04/2025 10:52:58